vs

Side-by-side financial comparison of BXP, Inc. (BXP) and Clorox (CLX). Click either name above to swap in a different company.

Clorox is the larger business by last-quarter revenue ($1.7B vs $872.1M, roughly 1.9× BXP, Inc.). BXP, Inc. runs the higher net margin — 15.3% vs 9.4%, a 5.9% gap on every dollar of revenue. On growth, BXP, Inc. posted the faster year-over-year revenue change (0.8% vs 0.3%). Over the past eight quarters, BXP, Inc.'s revenue compounded faster (1.3% CAGR vs -8.3%).

BXP Inc., operating as Boston Properties, is a leading U.S. real estate investment trust focused on owning, managing and developing high-quality Class A commercial office properties across major U.S. metro markets, serving diverse corporate, tech and professional service tenants.

The Clorox Company is an American multinational manufacturer and marketer of consumer and professional products. Clorox ranked annually on the Fortune 500 list from 2000 to 2024, where it last held the #485 spot.

BXP vs CLX — Head-to-Head

Bigger by revenue
CLX
CLX
1.9× larger
CLX
$1.7B
$872.1M
BXP
Growing faster (revenue YoY)
BXP
BXP
+0.5% gap
BXP
0.8%
0.3%
CLX
Higher net margin
BXP
BXP
5.9% more per $
BXP
15.3%
9.4%
CLX
Faster 2-yr revenue CAGR
BXP
BXP
Annualised
BXP
1.3%
-8.3%
CLX

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
BXP
BXP
CLX
CLX
Revenue
$872.1M
$1.7B
Net Profit
$133.0M
$157.0M
Gross Margin
43.2%
Operating Margin
Net Margin
15.3%
9.4%
Revenue YoY
0.8%
0.3%
Net Profit YoY
53.0%
-15.6%
EPS (diluted)
$1.69
$1.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BXP
BXP
CLX
CLX
Q1 26
$872.1M
Q4 25
$877.1M
$1.7B
Q3 25
$871.5M
Q2 25
$868.5M
$2.0B
Q1 25
$865.2M
$1.7B
Q4 24
$858.6M
$1.7B
Q3 24
$859.2M
$1.8B
Q2 24
$850.5M
$1.9B
Net Profit
BXP
BXP
CLX
CLX
Q1 26
$133.0M
Q4 25
$248.4M
$157.0M
Q3 25
$-121.7M
Q2 25
$89.0M
$332.0M
Q1 25
$61.2M
$186.0M
Q4 24
$-228.9M
$193.0M
Q3 24
$83.6M
$99.0M
Q2 24
$79.6M
$216.0M
Gross Margin
BXP
BXP
CLX
CLX
Q1 26
Q4 25
58.8%
43.2%
Q3 25
59.3%
Q2 25
59.2%
46.5%
Q1 25
59.2%
44.6%
Q4 24
59.7%
43.8%
Q3 24
59.5%
45.8%
Q2 24
59.8%
46.5%
Operating Margin
BXP
BXP
CLX
CLX
Q1 26
Q4 25
Q3 25
Q2 25
20.6%
Q1 25
15.2%
Q4 24
14.1%
Q3 24
10.0%
Q2 24
14.5%
Net Margin
BXP
BXP
CLX
CLX
Q1 26
15.3%
Q4 25
28.3%
9.4%
Q3 25
-14.0%
Q2 25
10.2%
16.7%
Q1 25
7.1%
11.2%
Q4 24
-26.7%
11.4%
Q3 24
9.7%
5.6%
Q2 24
9.4%
11.4%
EPS (diluted)
BXP
BXP
CLX
CLX
Q1 26
$1.69
Q4 25
$1.56
$1.29
Q3 25
$-0.77
Q2 25
$0.56
$2.68
Q1 25
$0.39
$1.50
Q4 24
$-1.46
$1.54
Q3 24
$0.53
$0.80
Q2 24
$0.51
$1.74

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BXP
BXP
CLX
CLX
Cash + ST InvestmentsLiquidity on hand
$512.8M
$227.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$7.7B
$-125.0M
Total Assets
$25.1B
$5.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BXP
BXP
CLX
CLX
Q1 26
$512.8M
Q4 25
$1.5B
$227.0M
Q3 25
$861.1M
Q2 25
$447.0M
$167.0M
Q1 25
$398.1M
$226.0M
Q4 24
$1.3B
$290.0M
Q3 24
$1.4B
$278.0M
Q2 24
$685.4M
$202.0M
Total Debt
BXP
BXP
CLX
CLX
Q1 26
Q4 25
Q3 25
Q2 25
$2.5B
Q1 25
Q4 24
Q3 24
Q2 24
$2.5B
Stockholders' Equity
BXP
BXP
CLX
CLX
Q1 26
$7.7B
Q4 25
$5.1B
$-125.0M
Q3 25
$5.0B
Q2 25
$5.3B
$321.0M
Q1 25
$5.3B
$27.0M
Q4 24
$5.4B
$-41.0M
Q3 24
$5.8B
$60.0M
Q2 24
$5.8B
$328.0M
Total Assets
BXP
BXP
CLX
CLX
Q1 26
$25.1B
Q4 25
$26.2B
$5.6B
Q3 25
$26.0B
Q2 25
$25.6B
$5.6B
Q1 25
$25.4B
$5.5B
Q4 24
$26.1B
$5.6B
Q3 24
$26.4B
$5.5B
Q2 24
$25.5B
$5.8B
Debt / Equity
BXP
BXP
CLX
CLX
Q1 26
Q4 25
Q3 25
Q2 25
7.74×
Q1 25
Q4 24
Q3 24
Q2 24
7.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BXP
BXP

Lease$818.2M94%
Parking and other$30.8M4%
Development and management services$9.2M1%

CLX
CLX

Health And Wellness$643.0M38%
Household$419.0M25%
Lifestyle$321.0M19%
Other$290.0M17%

Related Comparisons